Forest Laboratories, Inc. Forest Laboratories Holdings, Ltd., Merz Pharma GmbH & Co. KGaA, and Merz PharmaceuticalsGmbH announced today that the U.S. PTO has issued a Notice of Final Determination granting the full five years of patent term extension for U.S. Patent No. 5,061,703 (the '703 Patent), which is listed in the U.S. FDA Orange Book for NAMENDA(R) (memantine hydrochloride).
The details can be read here.
No comments:
Post a Comment